risedronic acid has been researched along with Airway Obstruction in 1 studies
Risedronic Acid: A pyridine and diphosphonic acid derivative that acts as a CALCIUM CHANNEL BLOCKER and inhibits BONE RESORPTION.
Airway Obstruction: Any hindrance to the passage of air into and out of the lungs.
| Excerpt | Relevance | Reference |
|---|---|---|
| "High lung deposition and bioavailability of RIS was monitored with 88." | 1.72 | Nebulization of risedronate alleviates airway obstruction and inflammation of chronic obstructive pulmonary diseases via suppressing prenylation-dependent RAS/ERK/NF-κB and RhoA/ROCK1/MLCP signaling. ( Cao, J; Chen, H; Chen, R; Liu, D; Su, B; Tang, Y; Wu, D; Xu, J; Xu, W, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, D | 1 |
| Xu, W | 1 |
| Tang, Y | 1 |
| Cao, J | 1 |
| Chen, R | 1 |
| Wu, D | 1 |
| Chen, H | 1 |
| Su, B | 1 |
| Xu, J | 1 |
1 other study available for risedronic acid and Airway Obstruction
| Article | Year |
|---|---|
Nebulization of risedronate alleviates airway obstruction and inflammation of chronic obstructive pulmonary diseases via suppressing prenylation-dependent RAS/ERK/NF-κB and RhoA/ROCK1/MLCP signaling.
Topics: Airway Obstruction; Animals; Inflammation; Lung; Mice; NF-kappa B; Prenylation; Pulmonary Disease, C | 2022 |